Mar 01, 2021 / 03:50PM GMT
Jayson Tyler Bedford - Raymond James & Associates, Inc., Research Division - Senior Medical Supplies and Devices Analyst
Okay. Good morning. I think we're live here. My name is Jayson Bedford. I'm the med device analyst here at Raymond James. Thank you for sharing a portion of your day with us here at the 42nd Annual Raymond James Institutional Investors Conference. We're privileged to have with us today the management team from DexCom. Specifically, we have Jereme Sylvain, SVP Finance, Chief Accounting Officer, and Sean Christensen, Head of IR.
So we're going to do a full fireside chat here, and I realize that you guys have covered a lot of topics over the last couple of weeks. But I'd like to cover 3 big topics: G7; awareness, specifically as it relates to the current business; and then maybe new market opportunities.
Questions and Answers:
Jayson Tyler Bedford - Raymond James & Associates, Inc., Research Division - Senior Medical Supplies and Devices AnalystSo let's start with G7. You mentioned on the last call that you've completed
Trustpilot
